Prevention of migraine recurrence

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/404 (2006.01) A61K 9/00 (2006.01) A61K 9/22 (2006.01) A61K 9/52 (2006.01) A61K 31/522 (2006.01) A61K 31/724 (2006.01) A61P 25/06 (2006.01)

Patent

CA 2338901

The invention relates to the use of eletriptan, or a pharmaceutically acceptable salt or composition thereof, for the manufacture of a medicament for the prevention of migraine recurrence and to the use of a 5- HT1B/1D receptor agonist, or a pharmaceutically acceptable salt or composition thereof, for the manufacture of a dual-, sustained-, delayed-, controlled- or pulsed-release pharmaceutical composition for the prevention of migraine recurrence.

L'invention concerne l'utilisation d'életriptane ou d'un sel pharmaceutiquement acceptable ou de sa composition pour la préparation d'un médicament permettant de prévenir des migraines récurrentes et l'utilisation d'un agoniste récepteur de 5-HT 1B/1D ou d'un sel pharmaceutiquement acceptable ou de sa composition pour l'élaboration d'une composition pharmaceutique à libération double, soutenue, retardée, régulée ou impulsée en vue de la prévention de migraines récurrentes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Prevention of migraine recurrence does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prevention of migraine recurrence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of migraine recurrence will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1840136

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.